NEW YORK, May 28 (GenomeWeb News) - NewCap Partners, a Los Angeles-based boutique investment-banking company, is helping Shanghai Genomics forge contract research alliances with US drug makers, according to a report on Forbes.com today.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.